{
    "meta": {
        "portal_name": "diseases-and-disorders",
        "language": "en",
        "updated": "20150503"
    },
    "schema": {
        "html:portal": "http://en.recuweb.com/diseases-and-disorders/",
        "graph:videos": "http://en.recuweb.com/graph/v1.0/diseases-and-disorders/diseases-and-disorders/videos.json",
        "graph:news": "http://en.recuweb.com/graph/v1.0/diseases-and-disorders/diseases-and-disorders/news.json",
        "graph:blogs": "http://en.recuweb.com/graph/v1.0/diseases-and-disorders/diseases-and-disorders/blogs.json"
    },
    "items": {
        "uncommonwisdomdaily.com/2015/05/breakthrough-cure-for-brain-diseases-uncommon-wisdom-daily": {
            "title": "Breakthrough Cure for Brain Diseases? - Uncommon Wisdom Daily...",
            "snippet": "Breakthrough Cure for Brain Diseases?Uncommon Wisdom DailyThat's because medical researchers have mostly focused on the brain as the sole source of neurological disorders. Now, with the number of people with neurodegenerative diseases on the rise,...",
            "date": "2015-05-02",
            "tags": "focused,brain,neurological,diseases,cure,disorders",
            "recuweb_url": "http://en.recuweb.com/uncommonwisdomdaily.com/2015/05/breakthrough-cure-for-brain-diseases-uncommon-wisdom-daily",
            "resource_url": "http://news.google.com/?hl=en&q=diseases%2Band%2Bdisorders&output=atom&nord=1",
            "source_url": "http://uncommonwisdomdaily.com/breakthrough-cure-for-brain-diseases-20460"
        },
        "indianexpress.com/2015/05/fir-against-snapdeal-ceo-kunal-bahl-5-firms-for-selling-drugs": {
            "title": "FIR against Snapdeal CEO Kunal Bahl, 5 firms for selling drugs online...",
            "snippet": "which prohibits certain drugs for treatment of certain diseases and disorders, including sexual performance enhancing drugs. We sent a notice to Snapdeal and in spite of their written commitment to delist the drugs from their website, we found...",
            "date": "2015-05-01",
            "categories": "drugs",
            "tags": "drugs,diseases,disorders",
            "recuweb_url": "http://en.recuweb.com/drugs/indianexpress.com/2015/05/fir-against-snapdeal-ceo-kunal-bahl-5-firms-for-selling-drugs",
            "resource_url": "http://www.bing.com/news/search?first=1&q=diseases%2Band%2Bdisorders&format=RSS&cc=us",
            "source_url": "http://indianexpress.com/article/business/business-others/fir-against-snapdeal-ceo-kunal-bahl-5-firms-for-selling-drugs-online/"
        },
        "phys.org/2015/05/training-pig-skin-cells-for-neural-development": {
            "title": "Training pig skin cells for neural development...",
            "snippet": "With this new technology, Stice plans to continue seeking grants from the National Institute of Neurological Diseases and Disorders and private funding for ALS and Alzheimer's.",
            "date": "2015-05-01",
            "categories": "institute,technology",
            "tags": "neurological,diseases,development,disorders",
            "recuweb_url": "http://en.recuweb.com/technology/phys.org/2015/05/training-pig-skin-cells-for-neural-development",
            "resource_url": "http://www.bing.com/news/search?first=1&q=diseases%2Band%2Bdisorders&format=RSS&cc=us",
            "source_url": "http://phys.org/news/2015-05-pig-skin-cells-neural.html"
        },
        "kplr11.com/2015/04/doctor-shares-way-to-keep-our-brains-healthy-strong": {
            "title": "Doctor shares way to keep our brains healthy, strong...",
            "snippet": "The same cannot be said for brain-related diseases and disorders. Cutting-edge science is now showing us that brain health and brain diseases are dictated by what goes on in the gut. New York Times bestselling author, Doctor David Perlmutter joins...",
            "date": "2015-04-30",
            "categories": "health,science",
            "tags": "joins,health,science,diseases,disorders",
            "recuweb_url": "http://en.recuweb.com/science/kplr11.com/2015/04/doctor-shares-way-to-keep-our-brains-healthy-strong",
            "resource_url": "http://www.bing.com/news/search?first=1&q=diseases%2Band%2Bdisorders&format=RSS&cc=us",
            "source_url": "http://kplr11.com/2015/04/30/doctor-shares-way-to-keep-our-brains-healthy-strong/"
        },
        "finance.yahoo.com/2015/04/minerva-neurosciences-to-host-first-quarter-2015-financial-results-webcast": {
            "title": "Minerva Neurosciences to Host First Quarter 2015 Financial Results Webcast and Conference Call...",
            "snippet": "April 30, 2015 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) diseases and disorders, today announced that...",
            "date": "2015-04-30",
            "tags": "stage,stage-biopharmaceutical,stage-biopharmaceutical-company,biopharmaceutical,biopharmaceutical-company,biopharmaceutical-company-focused,company,company-focused,focused,development,innovative,clinical,globe,globe_newswire,newswire,conference,inc,diseases,disorders",
            "recuweb_url": "http://en.recuweb.com/finance.yahoo.com/2015/04/minerva-neurosciences-to-host-first-quarter-2015-financial-results-webcast",
            "resource_url": "http://www.bing.com/news/search?first=1&q=diseases%2Band%2Bdisorders&format=RSS&cc=us",
            "source_url": "http://finance.yahoo.com/news/minerva-neurosciences-host-first-quarter-120000070.html"
        },
        "thestreet.com/2015/04/neurocrine-biosciences-to-present-at-the-deutsche-bank-40th-annual-health": {
            "title": "Neurocrine Biosciences To Present At The Deutsche Bank 40th Annual Health Care Conference...",
            "snippet": "focused on neurological and endocrine based diseases and disorders. The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and NBI-98854...",
            "date": "2015-04-30",
            "categories": "health,health-care",
            "tags": "inc,health,stage,clinical,focused,neurological,conference,diseases,disorders,company",
            "recuweb_url": "http://en.recuweb.com/health-care/thestreet.com/2015/04/neurocrine-biosciences-to-present-at-the-deutsche-bank-40th-annual-health",
            "resource_url": "http://www.bing.com/news/search?first=1&q=diseases%2Band%2Bdisorders&format=RSS&cc=us",
            "source_url": "http://thestreet.com/story/13133609/1/neurocrine-biosciences-to-present-at-the-deutsche-bank-40th-annual-health-care-conference.html"
        },
        "markets.financialcontent.com/2015/04/otonomy-appoints-george-morrow-to-board-of-directors": {
            "title": "Otonomy Appoints George Morrow to Board of Directors...",
            "snippet": "SAN DIEGO, April 30, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle...",
            "date": "2015-04-30",
            "tags": "inner,inner-and-middle,middle,stage,stage-biopharmaceutical,stage-biopharmaceutical-company,biopharmaceutical,biopharmaceutical-company,biopharmaceutical-company-focused,company,company-focused,focused,development,development-and-commercialization,commercialization,commercialization-of-innovative,innovative,innovative-therapeutics,therapeutics,clinical,globe,globe_newswire,newswire,san,san_diego,diego,otonomy,inc,nasdaq,otic,diseases,disorders",
            "recuweb_url": "http://en.recuweb.com/markets.financialcontent.com/2015/04/otonomy-appoints-george-morrow-to-board-of-directors",
            "resource_url": "http://www.bing.com/news/search?first=1&q=diseases%2Band%2Bdisorders&format=RSS&cc=us",
            "source_url": "http://markets.financialcontent.com/stocks/news/read?GUID=29777851"
        },
        "newsbreaks.infotoday.com/2015/04/nature-publishing-group-adds-new-format-to-its-journals-portfolio": {
            "title": "Nature Publishing Group Adds New Format to Its Journals Portfolio...",
            "snippet": "peer-reviewed journal that features a new format for NPG publicationsNRDP will contain review articles called Primers that have overviews of diseases and disorders, as well as an illustrated summary (PrimeView) alongside each article. NRDP will...",
            "date": "2015-04-29",
            "categories": "nature",
            "tags": "illustrated,diseases,disorders",
            "recuweb_url": "http://en.recuweb.com/nature/newsbreaks.infotoday.com/2015/04/nature-publishing-group-adds-new-format-to-its-journals-portfolio",
            "resource_url": "http://www.bing.com/news/search?first=1&q=diseases%2Band%2Bdisorders&format=RSS&cc=us",
            "source_url": "http://newsbreaks.infotoday.com/Digest/Nature-Publishing-Group-Adds-New-Format-to-Its-Journals-Portfolio-103615.asp"
        },
        "fool.com/2015/04/10-most-profitable-businesses-in-biotech": {
            "title": "10 Most Profitable Businesses in Biotech...",
            "snippet": "In other words, PDL's profit margin probably isn't sustainable. Targeted and rare-disease drugs Drug developers that target a specific disease, or which focus on rare diseases and disorders, are also prone to high profit margins. The reason is...",
            "date": "2015-04-28",
            "categories": "drugs,business",
            "tags": "rare,drugs,drug,diseases,disorders",
            "recuweb_url": "http://en.recuweb.com/business/fool.com/2015/04/10-most-profitable-businesses-in-biotech",
            "resource_url": "http://www.bing.com/news/search?first=1&q=diseases%2Band%2Bdisorders&format=RSS&cc=us",
            "source_url": "http://fool.com/investing/high-growth/2015/04/28/10-most-profitable-businesses-in-biotech.aspx"
        },
        "money.cnn.com/2015/04/otonomy-announces-fda-acceptance-of-auripro-tm-new-drug-application": {
            "title": "Otonomy Announces FDA Acceptance of AuriPro(TM) New Drug Application...",
            "snippet": "SAN DIEGO, April 28, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle...",
            "date": "2015-04-28",
            "tags": "inner,inner-and-middle,middle,stage,stage-biopharmaceutical,stage-biopharmaceutical-company,biopharmaceutical,biopharmaceutical-company,biopharmaceutical-company-focused,company,company-focused,focused,development,development-and-commercialization,commercialization,commercialization-of-innovative,innovative,innovative-therapeutics,therapeutics,clinical,globe,globe_newswire,newswire,san,san_diego,diego,drug,otonomy,inc,nasdaq,otic,diseases,disorders",
            "recuweb_url": "http://en.recuweb.com/money.cnn.com/2015/04/otonomy-announces-fda-acceptance-of-auripro-tm-new-drug-application",
            "resource_url": "http://www.bing.com/news/search?first=1&q=diseases%2Band%2Bdisorders&format=RSS&cc=us",
            "source_url": "http://money.cnn.com/news/newsfeeds/articles/globenewswire/10131065.htm"
        }
    }
}